Alimera Sciences Stock (NASDAQ: ALIM) stock price, news, charts, stock research, profile.
Open | $5.60 |
Close | $5.57 |
Volume / Avg. | 1.34M / 337.60K |
Day Range | 5.56 - 5.60 |
52 Wk Range | 2.61 - 5.65 |
Market Cap | $291.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 78 |
Short Interest | 3.01% |
Days to Cover | 2.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alimera Sciences (NASDAQ:ALIM) through any online brokerage.
Other companies in Alimera Sciences’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and Xeris Biopharma Holdings (NASDAQ:XERS).
There is no analysis for Alimera Sciences.
Alimera Sciences has a consensus price target of $6.00.
The stock price for Alimera Sciences (NASDAQ: ALIM) is $5.57 last updated July 26, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Alimera Sciences.
Alimera Sciences’s Q3 earnings are confirmed for Thursday, October 24, 2024.
There is no upcoming split for Alimera Sciences.
Alimera Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.